Medicare AdvantageCoverageMedium impact
MA11.056i, Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass Surgery
Independence Blue Cross·Vascular Surgery, Neurosurgery, Cardiothoracic Surgery·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.056i regarding Percutaneous Transluminal Angioplasty (PTA) with or without stenting and Extracranial-Intracranial arterial bypass surgery has been updated. This affects billing for complex vascular procedures involving angioplasty and bypass surgery combinations.
Action Required
Before January 1, 2026: Billing team must review updated policy MA11.056i for PTA and EC-IC arterial bypass surgery procedures. Contact Medicare Advantage plans to obtain specific coverage criteria, prior authorization requirements, and billing guidelines for these combined vascular procedures. Update billing protocols and inform vascular surgery providers of any new requirements.